Day: May 16, 2024

Nature’s Miracle and Agrify Corporation Announces Signing of the Definitive Merger Agreement

Written by Customer Service on . Posted in Mergers And Acquisitions.

Transaction Expected to Close in the Second Half of 2024 ONTARIO, Calif., May 16, 2024 (GLOBE NEWSWIRE) — Nature’s Miracle Holding Inc. (NASDAQ: NMHI; NMHIW) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology and infrastructure, and Agrify Corporation (NASDAQ: AGFY) (“Agrify”), announced today that both parties have signed a definitive agreement and plan of merger (“Agreement”) in which a new wholly-owned subsidiary of Nature’s Miracle will merge with and into Agrify, with Agrify surviving the merger as a wholly-owned subsidiary of Nature’s Miracle. The signing of the definitive agreement directly follows the previously announced term sheet for the merger. The Transaction Agrify shareholders who do not dissent to the merger will each be issued 0.45 of a share of Nature’s Miracle common stock for...

Continue reading

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported its financial results for the first quarter 2024. As previously announced, the Company will host a conference call and webcast today, Thursday, May 16, 2024, at 8:30 AM ET (details below). “AIM is making fundamental progress across our clinical development programs and continues to be encouraged by Ampligen’s potential. We recently reported encouraging top-line data across our pipeline. We also recently completed cGMP manufacturing of 9,000 vials of Ampligen. Both of these successes are extremely important...

Continue reading

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform

Written by Customer Service on . Posted in Public Companies.

LAS VEGAS, May 16, 2024 (GLOBE NEWSWIRE) — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence (AI) technology company specializing in the development of advanced AI and data center infrastructure solutions, today announced an ambitious plan to develop a cutting-edge, proprietary AI software platform to power its next-generation data centers. This advanced platform will leverage machine learning algorithms to analyze data, predict resource needs, and make real-time resource allocation decisions, ushering in a new era of intelligent and autonomous data center management. Avant is developing an AI platform specifically designed to address the unique challenges and opportunities of data center management. The platform will be built on proprietary machine-learning algorithms developed in-house....

Continue reading

Q1 2024 results in line with expectations. Full-year guidance narrowed

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Announcement no. 9-2024 16 May 2024 North Media CEO Lasse Ingemann Brodt commented on the results for Q1 2024:“In the first quarter of 2024, with performance in line with expectations, we focused on integrating SDR Svensk Direktreklam in the North Media Group. We have taken the first steps to exploit the potential for mutual development with FK distribution, including the transition to shared use of the Danish production systems and planned testing of automated packaging of printed matter for the Swedish market in Q2 2024. In Digital Services, the results were impacted by increased costs for strategic development of the businesses, which was expected. Based on greater insight into SDR’s business, we are narrowing our full-year guidance.” Guidance for 2024 The Group narrows its revenue and EBITDA guidance. Revenue is now expected to be...

Continue reading

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended March 31, 2024. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “I am pleased to report our domestic, direct sales strategy within our dental segment has proven effective, as a result of our new online sales portal, which recorded growth of 31% over the same period...

Continue reading

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

Written by Customer Service on . Posted in Public Companies.

HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD. HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in the American Journal of Kidney Diseases, providing evidence of Khure’s Clinical Co-Pilot’s utility to support improved CKD patient care by US Nephrologists. CKD is a major health problem affecting approximately one seventh of the population in North America. In Canada alone, the economic burden of chronic and end-stage kidney disease costs the national healthcare system more than $40 billion per year. WELL...

Continue reading

Jeffs’ Brands: Fort Amazon’s Revenues increased by 55% to $2.125 million in the First Quarter of 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Tel Aviv, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced preliminary unaudited financial results for Fort Products Ltd. (“Fort”), its wholly owned subsidiary, on its revenue for sales on Amazon Marketplace, according to the data received from the Amazon seller central. The following results are for the first quarter of 2024, starting on January 1, 2024, and ending on March 31, 2024 (the “Period”). Fort’s Amazon generated revenues for the Period, amounted to approximately $2.125 million (£1.7 million), representing an increase of 55% compared $1.375 million (£1.1 million) at the same period of 2023. Profit for the Period, attributed directly to Fort’s Amazon sales,...

Continue reading

AGF Investments Announces Final Distributions for AGF Global Opportunities Bond ETF, AGF Systematic Canadian Equity ETF and AGF Systematic Emerging Markets Equity ETF

Written by Customer Service on . Posted in Dividend Reports And Estimates.

TORONTO, May 16, 2024 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the final distributions for AGF Global Opportunities Bond ETF (ticker: AGLB), AGF Systematic Canadian Equity ETF (ticker: QCD) and AGF Systematic Emerging Markets Equity ETF (ticker: QEM) (each an “AGF Investments ETF” and collectively, the “AGF Investments ETFs”). These final distributions are the result of the previously announced termination of AGF Investments ETFs effective at the close of business on or about May 28, 2024 (the “ETF Termination Date”). Unitholders of record of an AGF Investments ETF on May 24, 2024 will receive notional distributions payable in respect of that AGF Investments ETF on May 24, 2024. The final distributions will not be paid in cash but will be reinvested in the form of a notional distribution and reported...

Continue reading

Marex Group plc Announces Full Year 2023 Results and Q1 2024 Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Transformational year thanks to successful organic growth and the benefit of acquisitions First quarter profit at the top end of range for preliminary results shows continued strong performance Positive momentum continued into the second quarter with good performance in April NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) — Marex Group plc (‘Marex’ or the ‘Group’), a diversified global financial services platform, announces strong results for the twelve months ended December 31, 2023, and a positive update for the first three months ended March 31, 2024. Ian Lowitt, Group Chief Executive Officer, commented: “2023 was another exceptional year where we transformed the scale and scope of the firm and maintained our record of delivering sequential growth over each of the last nine years, with an Adjusted Operating Profit compound...

Continue reading

Annual general meeting in IDEX Biometrics held on 16 May 2024

Written by Customer Service on . Posted in Public Companies.

IDEX Biometrics ASA held its annual general meeting on 16 May 2024. 95.3 million shares or 34% of the capital was represented at the meeting. All resolutions were passed as proposed by the board and nomination committee. The following board was elected at the meeting:Chair: Morten OpstadBoard members: Annika Olsson and Adriana Saitta. The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course. For further information contact: Marianne Bøe, Head of investor relations  E-mail: marianne.boe@idexbiometrics.com Tel: + 47 9180 0186  About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.